BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33420374)

  • 41. TIPE1 inhibits osteosarcoma tumorigenesis and progression by regulating PRMT1 mediated STAT3 arginine methylation.
    Yang M; Zhang Y; Liu G; Zhao Z; Li J; Yang L; Liu K; Hu W; Lou Y; Jiang J; Liu Q; Zhao P
    Cell Death Dis; 2022 Sep; 13(9):815. PubMed ID: 36151091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD
    He X; Zhu Y; Lin YC; Li M; Du J; Dong H; Sun J; Zhu L; Wang H; Ding Z; Zhang L; Zhang L; Zhao D; Wang Z; Wu H; Zhang H; Jiang W; Xu Y; Jin J; Shen Y; Perry J; Zhao X; Zhang B; Liu S; Xue SL; Shen B; Chen CW; Chen J; Khaled S; Kuo YH; Marcucci G; Luo Y; Li L
    Blood; 2019 Aug; 134(6):548-560. PubMed ID: 31217189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of protein arginine-methyltransferase 1 in gliomagenesis.
    Wang S; Tan X; Yang B; Yin B; Yuan J; Qiang B; Peng X
    BMB Rep; 2012 Aug; 45(8):470-5. PubMed ID: 22917032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PRMT1 activates myogenin transcription via MyoD arginine methylation at R121.
    Liu Q; Zhang XL; Cheng MB; Zhang Y
    Biochim Biophys Acta Gene Regul Mech; 2019 Oct; 1862(10):194442. PubMed ID: 31634638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Liu X; Wang Y; Zhao J
    Oncol Rep; 2017 Nov; 38(5):3187-3196. PubMed ID: 29048669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo.
    Herrmann F; Lee J; Bedford MT; Fackelmayer FO
    J Biol Chem; 2005 Nov; 280(45):38005-10. PubMed ID: 16159886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis.
    Li Z; Wang D; Lu J; Huang B; Wang Y; Dong M; Fan D; Li H; Gao Y; Hou P; Li M; Liu H; Pan ZQ; Zheng J; Bai J
    Cell Death Differ; 2020 Dec; 27(12):3226-3242. PubMed ID: 32895488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation.
    Yu Z; Chen T; Hébert J; Li E; Richard S
    Mol Cell Biol; 2009 Jun; 29(11):2982-96. PubMed ID: 19289494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
    Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
    Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA methylation-regulated and tumor-suppressive roles of miR-487b in colorectal cancer via targeting MYC, SUZ12, and KRAS.
    Chen X; Lin ZF; Xi WJ; Wang W; Zhang D; Yang F; Li YF; Huo Y; Zhang TZ; Jiang YH; Qin WW; Yang AG; Wang T
    Cancer Med; 2019 Apr; 8(4):1694-1709. PubMed ID: 30791232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells.
    Zhang Y; Wang D; Zhang M; Wei H; Lu Y; Sun Y; Zhou M; Gu S; Feng W; Wang H; Zeng J; Gong A; Xu M
    Exp Cell Res; 2018 Jan; 362(1):43-50. PubMed ID: 29097184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy.
    Abumustafa W; Castven D; Becker D; Salih SS; Manzoor S; Zamer BA; Talaat I; Hamad M; Marquardt JU; Muhammad JS
    Cell Signal; 2024 Jul; 119():111166. PubMed ID: 38588876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
    Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
    Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
    Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
    Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PRMT1 arginine methyltransferase accumulates in cytoplasmic bodies that respond to selective inhibition and DNA damage.
    Suchánková J; Legartová S; Sehnalová P; Kozubek S; Valente S; Labella D; Mai A; Eckerich C; Fackelmayer FO; Sorokin DV; Bartova E
    Eur J Histochem; 2014 May; 58(2):2389. PubMed ID: 24998928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-POU Domain-Containing Octomer-Binding (NONO) protein expression and stability promotes the tumorigenicity and activation of Akt/MAPK/β-catenin pathways in human breast cancer cells.
    Lone BA; Siraj F; Sharma I; Verma S; Karna SKL; Ahmad F; Nagar P; Sachidanandan C; Pokharel YR
    Cell Commun Signal; 2023 Jun; 21(1):157. PubMed ID: 37370134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c-Myc-mediated BCAT1 downregulation.
    Li Z; Meng D; Liu Y; Bi F; Tian K; Xu J; Sun J; Gu C; Li Y
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23537. PubMed ID: 37700640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs.
    Dhar S; Vemulapalli V; Patananan AN; Huang GL; Di Lorenzo A; Richard S; Comb MJ; Guo A; Clarke SG; Bedford MT
    Sci Rep; 2013; 3():1311. PubMed ID: 23419748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.